Prescription Drug Information: Duloxetine (Page 10 of 10)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 25000-608-06

Duloxetine Delayed-Release Capsules USP, 20 mg

60 count bottle label

dulo-20mg-60s
(click image for full-size original)

NDC 25000-609-03

Duloxetine Delayed-Release Capsules USP, 30 mg

30 count bottle label

dulo-30mg-30s
(click image for full-size original)

NDC 25000-609-07

Duloxetine Delayed-Release Capsules USP, 30 mg

90 count bottle label

dulo-30mg-90s
(click image for full-size original)

NDC 25000-610-03

Duloxetine Delayed-Release Capsules USP, 60 mg

30 count bottle label

dulo-60mg-30s
(click image for full-size original)

NDC 25000-610-07

Duloxetine Delayed-Release Capsules USP, 60 mg

90 count bottle label

dulo-60mg-90s
(click image for full-size original)
DULOXETINE duloxetine hydrochloride capsule, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25000-608
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DULOXETINE HYDROCHLORIDE (DULOXETINE) DULOXETINE 20 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSES
GLYCINE
SUCROSE
TALC
TRIETHYL CITRATE
GELATIN
TITANIUM DIOXIDE
FD&C BLUE NO. 2
SHELLAC
POTASSIUM HYDROXIDE
SODIUM LAURYL SULFATE
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
FERRIC OXIDE YELLOW
STARCH, CORN
FERROSOFERRIC OXIDE
Product Characteristics
Color GREEN (opaque green) Score no score
Shape CAPSULE Size 14mm
Flavor Imprint Code RDY608;20mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:25000-608-06 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090723 05/27/2022
DULOXETINE duloxetine hydrochloride capsule, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25000-609
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DULOXETINE HYDROCHLORIDE (DULOXETINE) DULOXETINE 30 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSES
GLYCINE
SUCROSE
TALC
TRIETHYL CITRATE
GELATIN
TITANIUM DIOXIDE
FD&C BLUE NO. 2
SHELLAC
SODIUM LAURYL SULFATE
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
STARCH, CORN
FERRIC OXIDE YELLOW
Product Characteristics
Color BLUE (opaque blue) Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code RDY609;30mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:25000-609-03 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE None
2 NDC:25000-609-07 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090723 05/27/2022
DULOXETINE duloxetine hydrochloride capsule, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25000-610
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DULOXETINE HYDROCHLORIDE (DULOXETINE) DULOXETINE 60 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSES
GLYCINE
SUCROSE
TALC
TRIETHYL CITRATE
GELATIN
TITANIUM DIOXIDE
FD&C BLUE NO. 2
SHELLAC
SODIUM LAURYL SULFATE
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)
STARCH, CORN
FERRIC OXIDE YELLOW
POTASSIUM HYDROXIDE
Product Characteristics
Color BLUE (opaque blue) Score no score
Shape CAPSULE Size 19mm
Flavor Imprint Code RDY610;60mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:25000-610-03 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE None
2 NDC:25000-610-07 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090723 05/27/2022
Labeler — MARKSANS PHARMA LIMITED (925822975)
Establishment
Name Address ID/FEI Operations
MARKSANS PHARMA LIMITED 925822975 MANUFACTURE (25000-608), MANUFACTURE (25000-609), MANUFACTURE (25000-610)

Revised: 10/2023 MARKSANS PHARMA LIMITED

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.